2024-05-19
2024-02-08
Summary | |
---|---|
Cancer Type | Uterine Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Western |
Gender | F |
Age | 52 |
Pathology Diagnosis | metastatic, stage iv, poorly differentiated uterine adenocarcinoma, refractorypoorly differentiated carcinoma |
Biopsy Site | terminal ileum & colon |
Treatment History | carboplatin/taxol x 4 cycles from month 1 to month 3 |
Pathology QC | Poorly differentiated endometrial adenocarcinoma with necrosis (P1) |
Special Features | from the same patient as UT5323 & UT5325. |
Mouse Strain | NOD SCID |
TMA | NA |
Viral Status in PDX | NA |
Available In | CB_SD |
RNA Seq | P1 |
Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy